Nutex Befektetesi Nyrt
BET:NUTEX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nutex Befektetesi Nyrt
BET:NUTEX
|
HU |
|
RWE AG
XETRA:RWE
|
DE |
|
B
|
Bangkok Land PCL
SET:BLAND
|
TH |
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
R
|
Rayong Wire Industries PCL
SET:RWI
|
TH |
|
FTGroup Co Ltd
TSE:2763
|
JP |
|
Neway CNC Equipment Suzhou Co Ltd
SSE:688697
|
CN |
|
B
|
Biovaxys Technology Corp
OTC:BVAXF
|
CA |
|
Greiffenberger AG
F:GRF
|
DE |
|
Paragon Technologies Co Ltd
TWSE:3518
|
TW |
|
MDU Resources Group Inc
NYSE:MDU
|
US |
|
C
|
CyberAgent Inc
OTC:CYAGF
|
JP |
|
Jinhui Liquor Co Ltd
SSE:603919
|
CN |
|
B
|
Banpu PCL
SET:BANPU
|
TH |
|
Wondershare Technology Group Co Ltd
SZSE:300624
|
CN |
|
N
|
Nordnet AB (publ)
STO:SAVE
|
SE |
|
Avid Bioservices Inc
NASDAQ:CDMO
|
US |
|
Silitech Technology Corp
TWSE:3311
|
TW |
|
3
|
3Dm Digital Manufacturing Ltd
TASE:DM3
|
IL |
|
N
|
Nam Viet Corp
VN:ANV
|
VN |
|
Stark Technology Inc
TWSE:2480
|
TW |
|
O
|
Oriental Times Media Corp
SZSE:002175
|
CN |
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
IN |
|
T
|
Thai Rubber Latex Group PCL
SET:TRUBB
|
TH |
Relative Value
The Relative Value of one NUTEX stock under the Base Case scenario is hidden HUF. Compared to the current market price of 14.6 HUF, Nutex Befektetesi Nyrt is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
NUTEX Competitors Multiples
Nutex Befektetesi Nyrt Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HU |
N
|
Nutex Befektetesi Nyrt
BET:NUTEX
|
2.3B HUF | 5 139.6 | 8.5 | 12.5 | 12.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |